12 – 14/10/2023 Thessaloniki Concert Hall IASIS PHARMA participated in the “44th PANHELLENIC CONGRESS OF CARDIOLOGY” which held on October 12-14, 2023, at Thessaloniki Concert Hall. The conference was organized by the Hellenic Society of Cardiology (HSC). The Panhellenic Congress of Cardiology has established among Cardiologists and the Pharmaceutical Industry, as the Scientific Conference par [...]
Qpain® is a new topical anti-inflammatory cutaneous solution, containing diclofenac sodium 1.5% w/w, indicated for the symptomatic relief of pain associated with osteoarthritis in superficial joints, including the knee. – Qpain® contains DMSO which enhances the absorption of diclofenac from the skin and reaches the focus of pain and inflammation directly. Ideal for those who cannot [...]
26.09.2023, Divani Caravel Hotel Athens Greece The Pharmaceutical Industry in Greece has completed 90 years since its foundation in 1933 as the Union of Pharmaceutical Laboratories which evolved into the Panhellenic Association of the Pharmaceutical Industry (P.E.F.). On Tuesday, 26.09.23, at a brilliant anniversary event at the "Divani Caravel" hotel, Panhellenic Association of Pharmaceutical Industries [...]
22 – 24/09/2023 Hermes Hotel, ERMOUPOLIS, SYROS ISLAND IASIS PHARMA participated in the "Developments in Dermatology & Venereology 2023" conference which held on September 22-24 2023, at the Hermes Hotel in Syros Island. The conference was organized by the Hellenic College of Dermatology-Venereology with the scientific support of the 2nd Clinic of Venereology and Skin [...]
Grecotel Filoxenia, Kalamata, 14-17/09/2023 During 14-17/09/2023, at Grecotel Filoxenia/KALAMATA, the Society for the Study of Dermatovenereologic and Allergic Diseases (S.S.D.A.D.) organized the 6th Panhellenic Conference “Dermatological diseases: Past, present and future”. Dermatologists from all over Greece who attended the Conference had the chance to visit IASIS PHARMA exhibition stand and received information about IASIS major Dermatological products: Isotroin®/Isotretinoin (in the new & [...]
Divani Caravel, Athens, 09-11/06/2023 IASIS PHARMA participated in the dermatological conference "ATTICA DERMATOLOGY DAYS", which was held on June 09-11, 2023, at the Divani Caravel hotel /Athens. The conference, which organized by the Hellenic College of Dermatology-Venereology, with the scientific support of the 2nd Clinic of Dermatology and Venereal Diseases EKPA, mainly concerned at the central [...]
IASIS PHARMA is pleased to announce the Nitrofurantoin/IASIS oral susp. launching in the oral suspension formulation. This Innovative Pharmaceutical Form is a global market leader. This dosage form is Research and Development by IASIS PHARMA HELLAS S.A. Each 5ml of oral suspension Nitrofurantoin/IASIS oral susp. contains 25mg of Nitrofurantoin monohydrate which, according to international literature, [...]
On Saturday, April 29th 2023, the Mastic Research Center (M.R.C.) opening was held in Kallimasia of Chios. Many people was present such as from the medical, pharmaceutical, business, political and academic field, as well as the mastic producers and guests. This project will be a reliable body that will coordinate academic interests and scientific research [...]
FIRA DE BARCELONA, GRAN VIA, BARCELONA, 4-6/10/2016 ΙΑSIS PHARMA was present for the second consecutive year, this time as a Gold zone exhibitor, at CPhI 2016, the top Fair of the Pharma Industry which took place in Barcelona, at October 4th-6th. During the three-day event, more than 36.000 visitors from over 150 countries had the [...]
DIVANI CARAVEL HOTEL, ATHENS, 19/12/2015 ΙΑSIS PHARMA participated, as it consistently does every year, in the Annual Winter Day Conference of the Hellenic Society of Dermatology and Venereology that took place at the DIVANI CARAVEL hotel, in Athens, 19 December 2015. ΙΑSIS PHARMA stand was visited by a high number of Dermatologists where two (2) of [...]
